Doliprane Divestiture And Tripartite Agreement: Towards Tighter Control Of Foreign Investment In France?
The sale of a controlling 50% stake in Opella, Sanofi's €15 billion consumer healthcare subsidiary responsible for Doliprane, to the US investment fund Clayton, Dubilier & Rice (CD&R)...